Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
about
G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?Predictive value of epigenetic alterations in head and neck squamous cell carcinomaImmortal Life of the Common Rule: Ethics, Consent, and the Future of Cancer ResearchEpigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancerGalanin plays an important role in cancer invasiveness and is associated with poor prognosis in stage II colorectal cancer.Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinomaAssociation between promoter methylation of DAPK gene and HNSCC: A meta-analysis.Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.Alterations in the neuropeptide galanin system in major depressive disorder involve levels of transcripts, methylation, and peptide.Epigenetic control of cancer by neuropeptides.Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis.Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis.Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer.Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis.Association of TET3 epigenetic inactivation with head and neck cancer.
P2860
Q26801162-456EF793-792D-48D1-8D10-69FFD42ACD10Q27690755-52BBB7A6-F4EF-43AD-BD77-9BE931CD7A81Q30085830-5F1F39D6-127B-4CDC-A1E6-EF26ED7778EFQ33791902-F298652A-5EF9-4F6E-810A-6E433121B6FCQ35012509-F1E13C6E-E84B-4A3B-B367-0433504879FBQ35143989-E803AC5D-3955-4268-A2F0-544AE3D5BEEBQ36294164-20F7AED0-FDB1-4AF0-B7D7-8EED8839CC81Q37295588-405B2D51-AA3B-4F0D-9476-22750C9FAA89Q37550046-58A7E348-494F-40B3-B49F-DC28F6FDC1ECQ38998556-131196F6-A869-4FB7-9BD0-E4476A8AEB14Q41120997-B1599562-20DE-4B5D-8FA6-9EB43761BDB9Q45501420-1B2B6B6A-C5B3-4A5C-BAE6-54124A7A12D6Q47961085-FCF4C960-E985-469A-A6D1-C32ED035DB1BQ48182545-ED98C7DD-43AA-42B6-9FCB-C7D0F4AAC2D3Q54247811-2693A0FE-DD99-4C34-BFEE-9567E3C440AFQ54997136-E20D3F2E-E422-4ADE-893A-26E046C5770FQ55280456-6076B3E8-3229-435C-8276-6E25EA2B799F
P2860
Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tumor suppressor activity and ...... ation in head and neck cancer.
@en
Tumor suppressor activity and ...... ation in head and neck cancer.
@nl
type
label
Tumor suppressor activity and ...... ation in head and neck cancer.
@en
Tumor suppressor activity and ...... ation in head and neck cancer.
@nl
prefLabel
Tumor suppressor activity and ...... ation in head and neck cancer.
@en
Tumor suppressor activity and ...... ation in head and neck cancer.
@nl
P2093
P2860
P356
P1433
P1476
Tumor suppressor activity and ...... ation in head and neck cancer.
@en
P2093
Hiroyuki Mineta
Kiyoshi Misawa
Shori Endo
Takashi Yamatodani
Takayuki Uehara
Takeharu Kanazawa
Yuki Misawa
P2860
P304
P356
10.1002/CNCR.28411
P407
P577
2013-10-10T00:00:00Z